Cetuximab-induced aseptic meningitis

Journal of Thoracic Oncology

Volumn 5, Issue 5, 2010, Pages 751-

  Nagovskiy, Nail ^a   Agarwal, Manoj ^a   Allerton, Jeffrey ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CETUXIMAB;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ANTIBIOTIC THERAPY; ARTICLE; ASEPTIC MENINGITIS; BRAIN DISEASE; CANCER RADIOTHERAPY; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DRUG INDUCED DISEASE; FEMALE; HEADACHE; HUMAN; LEUKOCYTE; LIVER TRANSPLANTATION; LUNG NON SMALL CELL CANCER; MALE; NAUSEA; NECK; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RIGIDITY; VOMITING;

EID: 77951786425     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181d408bc     Document Type: Article

References (4)

1. Ettinger DS. Emerging profile of cetuximab in non-small cell lung cancer. Lung Cancer, September 29, 2009 -Epub ahead of print-.
2. Baselga J, Pfister D, Cooper MR, et al. Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin. J Clin Oncol 2000;18:904-914.
3. Feinstein TM, Gibson MK, Argiris A. Cetuximab-induced aseptic meningitis. Ann Oncol 2009;20:1609-1610.
4. Thomas M. Cetuximab: adverse event profile and recommendations for toxicity management. Clin J Oncol Nurs 2005;9:332-338.